Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Watchlist
Price: 2 793.6 INR -0.8% Market Closed
Market Cap: 233.2B INR
Section:
 

Relative Value

The Relative Value of one LALPATHLAB stock under the Base Case scenario is hidden INR. Compared to the current market price of 2 793.6 INR, Dr. Lal PathLabs Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LALPATHLAB Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

9
P/S
P/S
Price to Sales
9
vs History
79
vs Industry
15
Median 3Y
9.6
Median 5Y
10.2
Industry
2.3
Forward
8.3
More Details
43.6
P/E
P/E
Price to Earnings
43.6
vs History
96
vs Industry
10
Median 3Y
63
Median 5Y
67.9
Industry
22.4
Forward
44.6
More Details
39.8
P/OCF
P/OCF
Price to OCF
39.8
vs History
80
vs Industry
8
Median 3Y
42.1
Median 5Y
45.1
Industry
14.4
More Details
73.8
P/FCFE
P/FCFE
Price to FCFE
73.8
vs History
55
vs Industry
7
Median 3Y
72
Median 5Y
76.2
Industry
21.5
More Details
9.8
P/B
P/B
Price to Book Value
9.8
vs History
92
vs Industry
5
Median 3Y
11.3
Median 5Y
12.6
Industry
2.2
More Details
8.5
EV/S
EV/S
Enterprise Value to Sales
8.5
vs History
80
vs Industry
14
Median 3Y
9.2
Median 5Y
9.8
Industry
2.5
Forward
7.9
More Details
10.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.5
vs History
87
vs Industry
20
Median 3Y
11.7
Median 5Y
12.4
Industry
5.1
More Details
29.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
29.9
vs History
92
vs Industry
10
Median 3Y
34.4
Median 5Y
36.4
Industry
12
Forward
28
More Details
37.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
37.3
vs History
95
vs Industry
11
Median 3Y
46.1
Median 5Y
47.8
Industry
17.1
Forward
34.6
More Details
37.7
EV/OCF
EV/OCF
Enterprise Value to OCF
37.7
vs History
82
vs Industry
10
Median 3Y
41.1
Median 5Y
43
Industry
14.7
More Details
54
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
54
vs History
31
vs Industry
12
Median 3Y
43
Median 5Y
45.8
Industry
18.8
More Details
15.5
EV/IC
EV/IC
Enterprise Value to IC
15.5
vs History
57
vs Industry
5
Median 3Y
15.6
Median 5Y
16.9
Industry
1.8
More Details

Multiples Across Competitors

LALPATHLAB Competitors Multiples
Dr. Lal PathLabs Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
233.2B INR 9 43.6 29.9 37.3
US
CVS Health Corp
NYSE:CVS
98.9B USD 0.3 211 13.9 13.9
US
Cigna Group
XMUN:CGN
62.6B EUR 0.3 12 7.7 9.8
US
Cigna Corp
NYSE:CI
72.5B USD 0.3 11.8 7.6 9.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR 1.2 23.6 10.3 15.7
DE
Fresenius Medical Care AG
XMUN:FME
23.6B EUR 1.2 32.9 10.3 22.1
US
Laboratory Corporation of America Holdings
NYSE:LH
21.1B USD 1.5 24.7 13.5 18.8
US
Quest Diagnostics Inc
NYSE:DGX
19.5B USD 1.8 20.3 11.3 15.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR 0.6 16.3 6.4 13.6
US
Guardant Health Inc
NASDAQ:GH
12.2B USD 13.5 -30.5 -32.3 -29.3
US
DaVita Inc
NYSE:DVA
8.3B USD 0.6 10.7 6.7 9.1

See Also

Summary
LALPATHLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
LALPATHLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LALPATHLAB stock valuation using valuation multiples.
Wall Street Estimates
LALPATHLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LALPATHLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.